Fenk R - Search Results

1

Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.

Papewalis C, Fassnacht M, Willenberg HS, Domberg J, Fenk R, Rohr UP, Schinner S, Bornstein SR, Scherbaum WA, Schott M. Papewalis C, et al. Among authors: fenk r. Clin Endocrinol (Oxf). 2006 Aug;65(2):215-22. doi: 10.1111/j.1365-2265.2006.02576.x. Clin Endocrinol (Oxf). 2006. PMID: 16886963

2

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.

Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Among authors: fenk r. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.

3

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.

Kobbe G, Schneider P, Rohr U, Fenk R, Neumann F, Aivado M, Dietze L, Kronenwett R, Hünerlitürkoglu A, Haas R. Kobbe G, et al. Among authors: fenk r. Bone Marrow Transplant. 2001 Jul;28(1):47-9. doi: 10.1038/sj.bmt.1703094. Bone Marrow Transplant. 2001. PMID: 11498743

4

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells.

Steidl U, Kronenwett R, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Aivado M, Koch J, Modlich O, Bojar H, Gattermann N, Haas R. Steidl U, et al. Among authors: fenk r. Blood. 2002 Mar 15;99(6):2037-44. doi: 10.1182/blood.v99.6.2037. Blood. 2002. PMID: 11877277 Free article.

5

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.

Rohr UP, Wulf MA, Stahn S, Heyd F, Steidl U, Fenk R, Opalka B, Pitschke G, Prisack HB, Bojar H, Haas R, Kronenwett R. Rohr UP, et al. Among authors: fenk r. Cancer Gene Ther. 2003 Dec;10(12):898-906. doi: 10.1038/sj.cgt.7700643. Cancer Gene Ther. 2003. PMID: 14712316

6

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators.

Steidl U, Bork S, Schaub S, Selbach O, Seres J, Aivado M, Schroeder T, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Bornstein SR, Haas HL, Kobbe G, Tenen DG, Haas R, Kronenwett R. Steidl U, et al. Among authors: fenk r. Blood. 2004 Jul 1;104(1):81-8. doi: 10.1182/blood-2004-01-0373. Epub 2004 Mar 11. Blood. 2004. PMID: 15016651 Free article.

7

Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.

Fenk R, Ak M, Kobbe G, Steidl U, Arnold C, Korthals M, Hünerlitürkoglu A, Rohr UP, Kliszewski S, Bernhardt A, Haas R, Kronenwett R. Fenk R, et al. Haematologica. 2004 May;89(5):557-66. Haematologica. 2004. PMID: 15136219

8

Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R. Rohr UP, et al. Among authors: fenk r. Int J Cancer. 2004 Aug 20;111(2):259-63. doi: 10.1002/ijc.20252. Int J Cancer. 2004. PMID: 15197780

9

Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R. Rohr UP, et al. Among authors: fenk r. Clin Cancer Res. 2005 Jan 1;11(1):180-5. Clin Cancer Res. 2005. PMID: 15671544

10

Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles.

Rohr UP, Heyd F, Neukirchen J, Wulf MA, Queitsch I, Kroener-Lux G, Steidl U, Fenk R, Haas R, Kronenwett R. Rohr UP, et al. Among authors: fenk r. J Virol Methods. 2005 Jul;127(1):40-5. doi: 10.1016/j.jviromet.2005.03.006. Epub 2005 Apr 12. J Virol Methods. 2005. PMID: 15893564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters